U.S. STOCKS ON THE MOVE-EyePoint Inc, Amer Sports, Pliant Therapeutics
BUZZ-U.S. STOCKS ON THE MOVE-EyePoint Inc, Amer Sports, Pliant Therapeutics August 18 (Reuters) - U.S. stocks were set to open lower on Tuesday, as diminishing prospects for a peace deal between the United States and Iran kept oil prices elevated and government bond yields at multi-year peaks. .N
** EyePoint Inc EYPT.O:
BUZZ - Falls after experimental drug misses goal, brokerages cut ratings nL6N44F06Z
** DocGo Inc DCGO.O:
BUZZ - Slips on tepid quarterly results, narrower annual outlook nL4N44F0EJ
** Baidu Inc BIDU.O:
BUZZ - Fall after downbeat Q2 revenue nL4N44F0H1
** Corebridge Financial Inc CRBG.N:
** Equitable Holdings Inc EQH.N:
** Brighthouse Financial Inc BHF.O:
** Lincoln National Corp LNC.N:
BUZZ - Life insurance stock weakness after Mark Walter headlines overdone, Evercore says nL6N44F0K3
** Dynatrace Inc DT.N:
BUZZ - Up after $1.25 bln convertible offering prices nL6N44F0O2
** Duolingo Inc DUOL.O:
BUZZ - Gains after D.A. Davidson upgrades rating, hikes price target nL4N44F0MI
** Amylyx Pharmaceuticals Inc AMLX.O:
BUZZ - Soars as blood sugar drug succeeds in late-stage trial nL4N44F0M1
** Einride AB ENRD.O:
BUZZ - Gains on upbeat forecast, Tesla partnership nL6N44F0TI
** Norwegian Cruise Line Holdings Ltd NCLH.N:
BUZZ - Falls as Mizuho downgrades stock to 'neutral' nL6N44F0UY
** Amer Sports Inc AS.N:
BUZZ - Up after raising annual forecasts nL6N44F0OT
** Prenetics Global Ltd PRE.O:
BUZZ - Rises on Q2 revenue jump nL6N44F0WC
** Pliant Therapeutics Inc PLRX.O:
BUZZ - Rises after FDA grants fast-track tag to experimental cancer drug nL4N44F0RE
(Compiled by Rajarshi Roy and Varun Sahay)
Recent news on Baidu
See all newsNvidia's China AI-chip share falls as Huawei closes gap, report finds
China AI developers publish safety tests for just 3.6% of model releases, report finds
Hong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
After outrunning Bolt, China's robot champion races towards real-world work